UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030646 |
|---|---|
| Receipt number | R000034990 |
| Scientific Title | Questionary survey of the percentage of inoculation of the influenza vaccine during the cancer duration of treatment |
| Date of disclosure of the study information | 2018/01/01 |
| Last modified on | 2018/04/24 10:31:12 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Questionary survey of the percentage of inoculation of the influenza vaccine during the cancer duration of treatment
Acronym
Questionary survey of the percentage of inoculation of the influenza vaccine during the cancer duration of treatment
Scientific Title
Questionary survey of the percentage of inoculation of the influenza vaccine during the cancer duration of treatment
Scientific Title:Acronym
Questionary survey of the percentage of inoculation of the influenza vaccine during the cancer duration of treatment
Region
| Japan |
Condition
Condition
all cancers
Classification by specialty
| Hematology and clinical oncology | Radiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To investigate that to took in influenza vaccine during cancer duration of treatment by questionary survey
Basic objectives2
Others
Basic objectives -Others
To know how you took in influenza vaccine by questionary survey during cancer duration of treatment
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
We examine frequency how you took in influenza vaccine by questionary survey during cancer duration of treatment
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 10 | years-old | <= |
Age-upper limit
| 90 | years-old | > |
Gender
Male and Female
Key inclusion criteria
All patients with cancer
Key exclusion criteria
The drug that influenza vaccine is contraindicated is given
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yuka Kunishima |
Organization
Asahi Univ. Murakami Memorial Hospital
Division name
Dept. of Radiation Oncology
Zip code
Address
3-23 Hashimoto-cho , Gifu, Gifu Pref.,Japan
TEL
058-2522-8001
kuni92.0805@gmail.com
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Osamu Tanaka |
Organization
Murakami Memorial hospital
Division name
Dept.of Radiation Oncology
Zip code
Address
3-32 Hashimoto-cho, Gifu, Gifu Pref.,Japan
TEL
058-252-8001
Homepage URL
c.bluered@gmail.com
Sponsor or person
Institute
Asahi Univ. Murakami Memorial Hospital
Institute
Department
Personal name
Funding Source
Organization
Asahi Univ.
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 01 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 10 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 11 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
none
Management information
Registered date
| 2017 | Year | 12 | Month | 30 | Day |
Last modified on
| 2018 | Year | 04 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034990
